Benzinga | May 13, 2021 07:09AM EDT

Precision BioSciences Q1 EPS $(0.33) Beats $(0.50) Estimate, Sales $16.30M Beat $7.11M Estimate

Precision BioSciences (NASDAQ:DTIL) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.50) by 34 percent. This is a 36.54 percent increase over losses of $(0.52) per share from the same period last year. The company reported quarterly sales of $16.30 million which beat the analyst consensus estimate of $7.11 million by 129.25 percent. This is a 132.92 percent increase over sales of $7.00 million the same period last year.